About Alnylam Pharma (ALNY)
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgala... Read more
- USD196.47
- USD197.91
- USD190.85
- USD242.97
- -1.50%
- 1.0B
- 587.49k
- 833.48k
- 23.6B
- 117.58
- 16.60%
Stock News
yesterday
Market Extra: Assets in money-market funds touch new $5.2 trillion record, ICI says
MarketWatch
yesterday
The Conversation: Trump indictment won’t keep him from presidential race, but will make his reelection bid much harder
MarketWatch
yesterday
: Virgin Orbit stock plunges after report says company will cease operations
MarketWatch
yesterday
: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged
MarketWatch
More Stock Analysis & Reports
Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.
